Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation

This study has been withdrawn prior to enrollment.
(Study was not initiated. No subjects were screened or enrolled.)
Sponsor:
Information provided by:
Wake Forest School of Medicine
ClinicalTrials.gov Identifier:
NCT00349401
First received: July 5, 2006
Last updated: June 2, 2015
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given